Detalhe da pesquisa
1.
A pilot study of toceranib/vinblastine therapy for canine transitional cell carcinoma.
BMC Vet Res
; 12(1): 257, 2016 Nov 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-27855679
2.
Erratum to: A pilot study of toceranib/vinblastine therapy for canine transitional cell carcinoma.
BMC Vet Res
; 12(1): 291, 2016 Dec 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-28038672
3.
Phase I/II evaluation of RV1001, a novel PI3Kδ inhibitor, in spontaneous canine lymphoma.
PLoS One
; 13(4): e0195357, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-29689086
4.
KTN0158, a Humanized Anti-KIT Monoclonal Antibody, Demonstrates Biologic Activity against both Normal and Malignant Canine Mast Cells.
Clin Cancer Res
; 23(10): 2565-2574, 2017 May 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-27815356